LIA
CL icon

Lynx Investment Advisory’s Colgate-Palmolive CL Stock Holding History

Lynx Investment Advisory’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-242
Closed -$23.5K – 251
2024
Q2 		$23.5K Buy
+242
New +$22.3K 0.02% 319

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Lynx Investment Advisory's CL Position: Q3 2024 in Review

Lynx Investment Advisory sold out of Colgate-Palmolive (CL) in Q3 2024, closing a stake of 242 shares — an estimated $23.5K sold.

Lynx Investment Advisory first reported a position in CL in Q2 2024 and held it in 1 quarter. The position peaked at $23.5K in Q2 2024. 1,909 funds tracked by Wall St. Rank hold CL as of Q3 2024.

  • Lynx Investment Advisory reported no remaining Colgate-Palmolive position as of Q3 2024 after selling out during the quarter.
  • Lynx Investment Advisory sold 242 Colgate-Palmolive shares in Q3 2024, an estimated $23.5K.
  • Lynx Investment Advisory first reported a position in Colgate-Palmolive in Q2 2024 and held it in 1 quarter.
  • Lynx Investment Advisory's Colgate-Palmolive position peaked at $23.5K in Q2 2024.
  • 1,909 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.

Based on Lynx Investment Advisory's 13F filing for Q3 2024, filed 4 Nov 2024.